AU6838500A - Composition for maintenance of bone or dental health or treatment of bone or dental disorders - Google Patents

Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Info

Publication number
AU6838500A
AU6838500A AU68385/00A AU6838500A AU6838500A AU 6838500 A AU6838500 A AU 6838500A AU 68385/00 A AU68385/00 A AU 68385/00A AU 6838500 A AU6838500 A AU 6838500A AU 6838500 A AU6838500 A AU 6838500A
Authority
AU
Australia
Prior art keywords
bone
dental
maintenance
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68385/00A
Inventor
Dominique Brassart
Fiona Ginty
Jean-Richard Neeser
Elisabeth Pasche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU6838500A publication Critical patent/AU6838500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU68385/00A 1999-08-31 2000-08-14 Composition for maintenance of bone or dental health or treatment of bone or dental disorders Abandoned AU6838500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9920578.3A GB9920578D0 (en) 1999-08-31 1999-08-31 Composition for maintenance of bone or dental health or treatment of bone or dental disorders
GB9920578 1999-08-31
PCT/EP2000/007919 WO2001015715A2 (en) 1999-08-31 2000-08-14 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Publications (1)

Publication Number Publication Date
AU6838500A true AU6838500A (en) 2001-03-26

Family

ID=10860095

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68385/00A Abandoned AU6838500A (en) 1999-08-31 2000-08-14 Composition for maintenance of bone or dental health or treatment of bone or dental disorders

Country Status (3)

Country Link
AU (1) AU6838500A (en)
GB (1) GB9920578D0 (en)
WO (1) WO2001015715A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100866008B1 (en) * 1999-10-19 2008-10-29 메이지 데어리즈 코포레이션 Preventives/remedies for metabolic bone diseases
JP4268785B2 (en) * 2002-04-11 2009-05-27 株式会社ロッテ Calcium absorption promoter and calcium phosphate crystal growth promoter
US6872565B2 (en) 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
US7517681B2 (en) 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
JP2004315477A (en) * 2003-04-18 2004-11-11 Tokyoto Koreisha Kenkyu Fukushi Shinko Zaidan Bone resorption inhibitor
FR2872047B1 (en) * 2004-06-23 2007-06-15 Oreal COMPOSITION FOR SENSITIVE SKINS COMBINING MINERAL AND PROBIOTIC CATION (S)
KR20070070153A (en) 2004-06-23 2007-07-03 로레알 Method and compositions useful for preventing and/or treating sensitive and/or dry skin
US7956031B2 (en) 2005-05-31 2011-06-07 Naidu Lp Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy
SE529199C2 (en) 2005-07-05 2007-05-29 Probi Ab Increased absorption
US8021659B2 (en) * 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
FR2920304B1 (en) 2007-09-04 2010-06-25 Oreal COSMETIC USE OF LYSAT BIFIDOBACTERIUM SPECIES FOR THE TREATMENT OF DROUGHT.
FR2920305B1 (en) 2007-09-04 2010-07-30 Oreal USE OF A SPECIFIC BIFIDOBACTERIUM LYSATE FOR THE TREATMENT OF SENSITIVE SKINS.
WO2010036876A2 (en) 2008-09-25 2010-04-01 New York University Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
FR2942719B1 (en) 2009-03-04 2011-08-19 Oreal USE OF PROBIOTIC MICROORGANISMS TO LIMIT SKIN IRRITATION
MX2012003302A (en) * 2009-09-17 2012-07-23 Danone Sa Pasteurised and fermented dairy product supplemented with calcium and vitamin d and procedure for preparing such product.
ES2365145B1 (en) * 2009-09-17 2012-09-13 Danone, S.A. FERMENTED PASTERIZED DAIRY PRODUCT AND PREPARATION PROCEDURE OF THE SAME.
US8951512B2 (en) * 2010-05-04 2015-02-10 New York University Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
WO2012024638A2 (en) 2010-08-20 2012-02-23 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
AU2014250113B2 (en) * 2013-04-03 2017-03-30 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
CN104152354A (en) * 2013-05-14 2014-11-19 仙农生物科技(上海)有限公司 Compound probiotics as well as production process and application thereof to leavening agent
PL3016667T3 (en) 2013-07-05 2023-02-06 Stellar Biome Inc. Probiotic bacterial strains for the prevention and treatment of diseases in the oral cavity
CN104186655B (en) * 2014-08-27 2016-06-29 内蒙古伊利实业集团股份有限公司 There is low-fat yogurt of blood fat reducing and anti-oxidation function and preparation method thereof
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
CN106858605A (en) * 2016-12-26 2017-06-20 吉林舒润生物科技有限公司 A kind of probiotics calcium functional food for preventing and treating bone information relevant disease
CN108245479B (en) * 2017-09-19 2020-11-20 魏珂 Facial mask containing bifidobacterium lactis fermented active extract
CN110964656B (en) * 2018-09-30 2021-05-28 内蒙古伊利实业集团股份有限公司 Bifidobacterium lactis BL-99 capable of preventing osteoporosis and application thereof
EP3812452A4 (en) 2018-09-30 2021-11-03 Inner Mongolia Yili Industrial Group Co., Ltd. Bifidobacterium lactis bl-99 and application thereof
WO2021112041A1 (en) * 2019-12-02 2021-06-10 雪印メグミルク株式会社 Bone-strengthening agent
KR102198552B1 (en) * 2020-06-09 2021-01-05 주식회사 비피도 Composition improving, preventing or treating halitosis or dental caries comprising Lactobacillus fermentum OK derived from human oral cavity
KR102198553B1 (en) * 2020-06-09 2021-01-05 주식회사 비피도 Composition improving, preventing or treating halitosis or dental caries comprising Lactobacillus gasseri HHuMIN D derived from human oral cavity
CN114711355A (en) * 2022-04-21 2022-07-08 暨南大学 Composite organic acid high-calcium probiotic drink taking astragalus polysaccharide as raw material as well as preparation method and application thereof
CN116904378B (en) * 2023-09-14 2023-12-29 山东中科嘉亿生物工程有限公司 Lactobacillus johnsonii JYLO-010 for promoting bone growth, microbial inoculum and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273485A3 (en) * 1986-11-25 1988-07-27 Verenigde Coöperatieve Melkindustrie Coberco B.A. A process for preparing a raw material for human food; human food; a process for preparing a pharmaceutical composition
US5785990A (en) * 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same

Also Published As

Publication number Publication date
WO2001015715A2 (en) 2001-03-08
GB9920578D0 (en) 1999-11-03
WO2001015715A3 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU6838500A (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
GB0010669D0 (en) Compositions for treatment of disorders of the oesophagus
HUP9802319A3 (en) Pharmaceutical compositions for treatment of bone deficit conditions
IL147440A0 (en) Composition for treatment of external secretion disorders
EP0961613A4 (en) Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
AU2002252373A1 (en) Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
AU2001261637A1 (en) Apparatus for treatment of spinal disorders
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
EP1173470A4 (en) Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
IL146131A0 (en) Treatment of neurotic disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
IL162053A0 (en) Method for the treatment of bone disorders
AU2002235202A1 (en) Treatment of bone disorders by modulation of fgfr3
HUP0101748A3 (en) Use of reboxetine for producing pharmaceutical compositions suitable for treating nervous disorders
AU2683500A (en) Compositions for the treatment of pain
AU2002348324A1 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 46566
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
EP1440169A4 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 57749
AU2002360318A1 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 9805
AUPQ212899A0 (en) Composition & method for the prevention & treatment of skin disorders
AU2003245011A1 (en) Method and compositions for treatment of bone disorders
AU2002363126A1 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 57749
AU2002363229A1 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 2047

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase